La psicología ante la terapia electroconvulsiva (II)Consensos interesados a falta de evidencia

  1. David González-Pando 1
  2. César Luís Sanz de la Garza 2
  3. Víctor Aparicio-Basauri 3
  4. Tatiana Arboleya 2
  5. Ana María González-Menéndez 4
  6. Alicia Méndez-Salguero 2
  7. Marino Pérez-Álvarez 4
  1. 1 Facultad de Enfermería de Gijón
  2. 2 Servicio de Salud del Principado de Asturias (SESPA)
    info

    Servicio de Salud del Principado de Asturias (SESPA)

    Oviedo, España

  3. 3 Comité Científico Internacional del Lisbon Institute of Global Mental Health
  4. 4 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

Mostrar afiliaciones +
Revista:
Papeles del psicólogo

ISSN: 0214-7823,  1886-1415

Año de publicación: 2020

Título del ejemplar: Hacia la integración de la psicoterapia

Volumen: 41

Número: 2

Páginas: 132-138

Tipo: Artículo

DOI: 10.23923/PAP.PSICOL2020.2924 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Papeles del psicólogo

Objetivos de desarrollo sostenible

Resumen

This paper and its first part attempt to comprehend the use of electroshock, a technique whose effectiveness has not been unequivocally demonstrated. The lack of conclusive evidence has generated consensus, but it does not come from a genuine interdisciplinary debate. The concept of therapeutic inhibition is unfounded. Electroshock reduces the sense of personal efficacy and autonomy that characterizes a healthy functioning and introduces an implicit stigmatizing message of causality in terms of brain malfunction. There are no specific laws in Spain that regulate this procedure. The quality of the information provided to the patient is poor and could lead to professional liability. Due to its exceptional nature, electroshock should not be considered as a therapy like any other. Professionals can exercise conscientious objection for ethical and scientific reasons. An interdisciplinary perspective would be to call for potentially less harmful treatment alternatives.

Referencias bibliográficas

  • American Psychiatric Association (1978). The practice of electroconvulsive therapy: A task force report. Washington D.C: Author.
  • American Psychiatric Association (2001). The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. 2nd Ed. Washington, D.C: Author.
  • Andreasen, N. (1985). The broken brain: The biological revolution in psychiatry. New York: Harper & Row.
  • Avery, D. & Winokur, G. (1976). Mortality in depressed patients treated with electroconvulsive therapy and depressants. Archives of General Psychiatry, 33, 1029–1037.
  • Bentall, R.P. (2011). Medicalizar la mente. Barcelona: Herder.
  • Breggin, P.R. (1998). Electroshock: Scientific, ethical, and political issues. International Journal of Risk & Safety in Medicine, 11(1), 5-40.
  • Breggin, P. R. (2010). The FDA should test the safety of ECT machines. International Journal of Risk & Safety in Medicine, 22(2), 89-92.
  • Chakrabarti, S., Grover, S., & Rajagopal, R. (2010). Electroconvulsive therapy: A review of knowledge, experience and attitudes of patients concerning the treatment. World Journal of Biological Psychiatry, 11(3), 525-537.
  • Crow, T. & Johnstone, E. (1986). Controlled trials of electroconvulsive therapy. Annals of the New York Academy of Sciences, 462, 12–29.
  • Fosse, R. & Read, J. (2013). Electroconvulsive treatment: Hypotheses about mechanisms of action. Frontiers in Psychiatry, 4, 94-103.
  • Grupo de trabajo de la Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto (2014). Guía de práctica clínica sobre el manejo de la depresión en el adulto. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad.
  • Haslam, N. (2006). Deshumanization: An integrative review. Personality and Social Psychology Review, 10, 252-264.
  • Johnson, S., Sathiyaseelan, M., Charles, H., Jeyaseelan, V., & Jacob, K.S. (2012). Insight, psychopathology, explanatory models and outcome of schizophrenia in India: A prospective 5-year cohort study. BMC Psychiatry, 12(1), 159.
  • Kvaale, P., Haslam, N., & Gottdiener, W. (2013). The ‘side effects’ of medicalization: A meta-analytic review of how biogenetic explanations affect stigma. Clinical Psychology Review, 33, 782–794.
  • Lam, D. C., Salkovskis, P. M., & Warwick, H. M. (2005). An experimental investigation of the impact of biological versus psychological explanations of the cause of “mental illness”. Journal of Mental Health, 14, 453-464.
  • Leiknes, K., Jarosh-von, L., & Høie, B. (2012). Contemporary use and practice of electroconvulsive therapy worldwide. Brain and Behaviour, 2, 283–344.
  • López, E. y Costa, M. (2012). Desvelar el secreto de los enigmas. Despatologizar la psicología clínica. Papeles del Psicólogo, 33(3), 162-171.
  • Lysaker, P. H., Erikson, M., Macapagal, K. R, Tunze, C., Gilmore, E., & Ringer, J. M. (2012). Development of perso- nal narratives as a mediator of the impact of deficits in social cognition and social withdrawal on negative symptoms in schizophrenia. Journal of Nervous and Mental Disesase, 200, 290-295.
  • Munk-Olsen, T., Laursen, T. M., Videbech, P., Mortensen, P. B., & Rosenberg, R. (2007). All-cause mortality among recipients of electroconvulsive therapy: Register-based cohort study. The British Journal of Psychiatry, 190(5), 435-439.
  • National Institute of Care and Excellence (2009). Guidance on the use of electroconvulsive therapy: Technology appraisal guidance TA59. London, U.K: Author.
  • National Institute of Clinical Excellence (2017). Depression in adults: Recognition and management. Recuperado de: https://www.NICE.org.uk/guidance/cg90/chapter/1- Guidance.
  • Paino, M., García, L., y Ordóñez, N. (2019). Tratamientos integrados multimodales en psicosis. En E. Fonseca (Coord.), Tratamientos psicológicos para la psicosis (pp. 321- 344). Madrid: Pirámide.
  • Pérez-Álvarez, M. (2011). Esquizofrenia y cultura moderna. Oviedo: Ediuno.
  • Pérez-Álvarez, M. & García-Montes, J. M. (2007). The Charcot effect: The invention of mental illnesses. Journal of Constructivist Psychology, 20(4), 309-336.
  • Rasmussen, K.G. (2009). Sham electroconvulsive therapy studies in depressive illness: A review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice. The Journal of ECT, 25(1), 54-59.
  • Read, J. (2004). Electroconvulsive Therapy. En J. Read, L. R. Mosher, & R. P. Bentall, Models of madness. Psychological, social and biologycal aprroaches to schizophrenia (pp. 85-100). New York: Brunner-Routledge.
  • Read, J., & Arnold, C. (2017). Is electroconvulsive therapy for depression more effective than placebo? A systematic review of studies since 2009. Ethical Human Psychology and Psychiatry, 19(1), 5-23.
  • Read, J. & Bentall, R. (2010). The effectiveness of electroconvulsive therapy: A literature review. Epidemiology and Psychiatric Sciences, 19(4), 333-347.
  • Read, J., Cunliffe, S., Jauhar, S., & McLoughlin, D. M. (2019). Should we stop using electroconvulsive therapy? British Journal of Psychiatry, 364, 1-3.
  • Read, J., Haslam, N., Sayce, L., & Davies, E. (2006). Prejudi- ce and schizophrenia: A review of the mental ilness is a illness like any other aproach. Acta Psychiatrica Scandinavica, 114, 303-318.
  • Read, J., Harrop, C., Geekie, J., & Renton, J. (2017). An audit of ECT in England 2011–2015: Usage, demographics, and adherence to guidelines and legislation. Psychology and Psychotherapy: Theory, Research and Practice, 91(3), 263-277.
  • Robertson, H. & Pryor, R. (2006). Memory and cognitive effects of ECT: Informing and assessing patients. Advances in Psychiatric Treatment, 12(3), 228-237.
  • Rose, D., Wykes, T., Leese, M., Bindman, J., & Fleischmann, P. (2003). Patients’ perspectives on electroconvulsive therapy: Systematic review. British Medical Journal, 326, 1–5.
  • Ross, C. A. (2006). The sham ECT literature: Implications for consent to ECT. Ethical Human Psychology and Psychiatry, 8(1), 17.
  • Sackeim, H. A., Prudic, J., Fuller, R., Keilp, J., Lavori, P. W., & Olfson, M. (2007). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology, 32, 244–254.
  • Sanz-Fuentenebro, F.J. (2018). Características del estímulo en terapia electroconvulsiva. Una revisión pragmática. Revista de Psiquiatría y Salud Mental, 11(1), 36-47.
  • Sanz-Fuentenebro, F.J., Vera, I., Verdura, E., Urretavizcaya, M., Martínez-Amorós, … Bernardo, M. (2017). Patrón de uso de la terapia electroconvulsiva en España: Propuesta para una práctica óptima y acceso equitativo. Revista de Psiquiatría y Salud Mental, 10(2), 87-95.
  • Seniuk, P. (2018). I’m shocked: informed consent in ECT and the phenomenological-self. Life Sciences, Society and Policy, 14(5), 1-19.
  • Smith, M., Vogler, J., Zarrouf, F., Sheaves, C., & Jesse, J. (2009). Electroconvulsive therapy: The struggles in the decision-making process and the aftermath of treatment. Issues in Mental Health Nursing, 30(9), 554-559.
  • Sociedad Española de Psiquiatría Biológica (2018). Consenso español sobre terapia electroconvulsiva. Madrid: autor.
  • Sterling, P. (2000). ECT damage is easy to find if you look for it. Nature, 402, 242.
  • UK ECT Review Group (2003). Efficacy and safety of ECT in depressive disorders. Lancet, 361, 799-808.
  • Vallejo, J. (2011). Introducción a la psicopatología y la psiquiatría (7ª Ed.). Barcelona: Elssevier.
  • Valverde, M.A. e Inchauspe, J.A. (2017). El encuentro entre el usuario y los servicios de salud mental: Consideraciones éticas y clínicas. Revista de la Asociación Española de Neuropsiquiatría, 37(132), 529-552.
  • Weiner, R. (1984). Does ECT cause brain damage? Behavioral and Brain Sciences, 7, 1-53.
Fuente de los datos: Dialnet